ºÚÁϳԹÏ×ÊÔ´

Charalampos Tzoulis is Professor of Neurology and Neurogenetics at the University of Bergen and Haukeland University Hospital in Bergen, Norway. He serves as Director of the Neuro-SysMed Center of Excellence for Clinical Neurological Research (), where he leads the clinical neurodegeneration program. He is also Head of the DECODE-PD Research Group (), and Director of the KG Jebsen Center for Parkinson's Disease (), the Mohn Center for Neuroprotection, and the Innovation Center for Neuroresilience (ICoN).

An internationally recognized expert in movement disorders and neurodegeneration, Prof. Tzoulis has made significant scientific contributions, to understanding the role of mitochondrial dysfunction, bioenergetics, and cellular vulnerability in Parkinson’s disease and related α-synucleinopathies. His work integrates molecular mechanisms, biomarker discovery, and translational neuroscience with innovative early- and late-phase clinical trials.

He currently leads a comprehensive research portfolio spanning Phase 1–3 clinical trials, as well as national platform-based multi-arm, multi-stage (MAMS) infrastructures such as SLEIPNIR and HYDRA, designed to accelerate the development of neuroprotective and disease-modifying therapies for Parkinson’s disease.

Neurodegenerative diseases remain an unsolved mystery: 

2018 Head of compulsory national course in neurogenetics for training neurologists

2010 – current Advanced training of neurologists in neurogenetics and movement disorders, at national and international (Europe & USA) courses and workshops.

2010 – current Advanced training of movement disorders specialists in botulinum toxin injection

2010 – current Teaching & examining residents for board specialization in Neurology

2007 – current Supervision of pre-graduate thesis projects, University of Bergen, Norway

2006 – current Teaching medical students in clinical neurology, University of Bergen, Norway.

For the most up-to-date publications, please see , or records. 

For our up-to-date reserach projects, please check the group website: